2 ms·
They stop making it, and pay generic manufacturers not to. https://www.nbcnews.com/business/business-news/drug-firms-stave-generics-costing-consumers-billions-
by ceejayoz 3y ago
They stop making it, and pay generic manufacturers not to.
https://www.nbcnews.com/business/business-news/drug-firms-stave-generics-costing-consumers-billions-critics-say-n447916 https://www.nbcnews.com/business/business-news/drug-firms-st...
> Known as "reverse settlement payments," or "pay-to-delay" deals, the financial arrangements are a unique but common practice in the pharmaceutical industry. Essentially, they allow drug manufacturers in some instances to pay competitors not to manufacture generic versions of their products, thereby ensuring that they maintain patent protection for as long as possible.
- RandomBK 3y agoHow is this not a blatent antitrust violation?
- ceejayoz 3y agoThe story of that particular legal saga is well laid out at https://www.theatlantic.com/ideas/archive/2023/06/pharmaceutical-generic-drugs-pay-for-delay/674410/ https://www.theatlantic.com/ideas/archive/2023/06/pharmaceut.... FTC is trying, but it's one of many places in society where money speaks loudly. https://www.ftc.gov/news-events/topics/competition-enforcement/pay-delay https://www.ftc.gov/news-events/topics/competition-enforceme...